BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2011

Jul 8, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2011-07-01

Reporting Person: STAAB THOMAS R II (Senior Vice President and CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.78	2021-07-01	Common Stock (200000)		Direct

Footnotes

F1: Restricted stock award. Will vest on the first anniversary of the date of grant, subject to continued employment on such vesting date.

F2: Options become exercisable at a rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.